Eribulin Mesylate Injection
Product Images NDC 68462-770
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Eribulin Mesylate (NDC 68462-770). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image2 (Image2)
Image3 (Image3)
Image4 (Image4)
Image5 (Image5)
Image6 (Image6)
This is a description of a sterile solution of Eribulin Mesylate in a single-dose vial at a concentration of 1 mg/2 mL. It is important to store the solution at 25°C (77°F) and avoid freezing or refrigeration. The product is a cytotoxic agent for intravenous use and any unused portion of the vial should be discarded. This medication is distributed by Glenmark Pharmaceuticals Inc., USA, and is a product of China. The text references additional prescribing information for dosage and use.*
Image7 (Image7)
This text is related to a medication called Eribulin Mesylate, which is a sterile solution for intravenous use. It is a cytotoxic agent and comes in single-dose vials containing 1 mg of eribulin mesylate in 2 ml of solution, with each ml containing 0.5 mg of eribulin. The solution also contains dehydrated alcohol and water for injection. The medication should be stored at room temperature (25°C) and protected from freezing or refrigeration. It is distributed by Glenmark Pharmaceuticals Inc., USA. Please refer to the accompanying prescribing information for dosage and usage instructions.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.